5 Set-It-and-Forget-It Stocks to Buy Right Now

Page 1 of 5

In this article, we will take a look at the 5 Set-It-and-Forget-It Stocks to Buy Right Now. For a deeper discussion and an expanded list, please see 10 Set-It-and-Forget-It Stocks to Buy Right Now.

5. Gilead Sciences Inc. (NASDAQ:GILD)

Gilead Sciences Inc. (NASDAQ:GILD) ranks among the best set-it-and-forget-it stocks to buy right now. Cantor Fitzgerald restated an Overweight rating and a $155 price target for Gilead Sciences Inc. (NASDAQ:GILD) on June 9, following the company’s clinical research findings.

Gilead Sciences Inc. (NASDAQ:GILD), in collaboration with Merck, revealed solid top-line results from the phase 3 ISLEND-1 and ISLEND-2 studies of weekly islatravir/lenacapavir for HIV medication. Additionally, the companies reported negative findings from the EVOKE-03 study comparing Trodelvy with Keytruda versus Keytruda monotherapy in patients with first-line PD-L1 non-small cell lung cancer.

Moreover, on June 8, RBC Capital reaffirmed its $122 Sector Perform rating for Gilead Sciences Inc. (NASDAQ:GILD). The firm made remarks regarding the company’s position in the domain of in vivo CAR-T treatment.

The firm added that in vivo CAR-T represents a possible risk to a sector that is estimated to account for 10-15% of Gilead’s potential revenue. According to RBC Capital, Gilead Sciences Inc. (NASDAQ:GILD) has begun to build promising technology in the field with differentiating features and a wide approach that incorporates current experience.

Gilead Sciences Inc. (NASDAQ:GILD) is a drug manufacturer that develops medicines for unmet medical needs. The company provides treatments for HIV-1, chronic hepatitis C, primary biliary cholangitis, chronic hepatitis B, and serious invasive fungal infections. It also offers T-cell and CAR T-cell therapies for adult patients, intravenous injections, and treatments for COVID-19.

Page 1 of 5
1281292 - 11759070 - 1